GRACEcast Bladder Cancer Video

By cancerGRACE - H. Jack West, MDMedicine Education

GRACEcast Bladder Cancer Video episodes

April 12, 2013 Dr. Rosalyn Juergens on "I Just Found Out I Have an EGFR Mutation, and I'm in the Middle of Chemo. What Now?"
Dr. Rosalyn Juergens, McMaster University, offers her view on the best way to approach the common scenario of an EGFR mutation or other "driver mutation" being identified after a patient is already on first line chemotherapy. When should we switch from one treatment to another?
2 min
April 12, 2013 Dr. Larry Einhorn on "What Have Been the Most Significant Changes in Cancer Care over the Past Decade or Two?"
Dr. Larry Einhorn, Distinguished Professor of Medicine at Indiana Univ and former ASCO president, on what he sees as the most significant changes in cancer care in the last decade or two.
2 min
April 12, 2013 Dr. Ravi Salgia on "Which patients do you send molecular marker testing for, and what tests do you seek?"
Dr. Ravi Salgia from University of Chicago describes which patients with advanced NSCLC he seeks molecular marker testing on, and the particular markers he prioritizes.
1 min
April 12, 2013 Dr. Geoffrey Oxnard: Are Patients or Payers Objecting to Repeat Biopsy?
Dr. Geoffrey Oxnard, Dana Farber Cancer Institute, discusses the issue of patients or payers objecting to repeat biopsies.
2 min
April 11, 2013 Dr. Greg Riely on Muliplex Next Generation Sequencing and its Effect on Molecular Oncology Practice
Dr. Greg Riely, from Memorial Sloan-Kettering, discusses the concept of multiplex next generation sequencing and how it could change molecular oncology.
4 min
April 11, 2013 Dr. Phil Bonomi on the Most Promising Upcoming New Targeted Agents and Molecular Pathways for Lung Cancer Treatment
Dr. Phil Bonomi, from Rush University, provides his view on the targeted therapy approaches most likely to become clinically useful in lung cancer over the next several years.
3 min
April 10, 2013 Dr. Karen Kelly on "My Approach to Maintenance Therapy for Advanced NSCLC"
Dr. Karen Kelly of the University of California, Davis, discusses the evidence and her personal interpretation and recommended approach to maintenance therapy for advanced non-small cell lung cancer.
3 min
April 10, 2013 Dr. David Spigel on the Utility of Molecular Marker Results in the Adjuvant Setting for Early Stage Non-Small Cell Lung Cancer
Dr. David Spigel addresses the question of whether to obtain molecular marker results in patients with early stage lung cancer and what to do with that information if it is available for potential application in the adjuvant setting.
2 min
April 09, 2013 Dr. Matthew Katz: Defining Resectability of Pancreatic Cancer (video)
Dr. Matthew Katz, surgeon at MD Anderson Cancer Center, discusses the factors that determine whether a person's pancreatic cancer is resectable and the importance of this factor in predicting clinical outcomes.
10 min
April 09, 2013 Dr. Matthew Katz: Defining Resectability of Pancreatic Cancer (audio)
Dr. Matthew Katz, surgeon at MD Anderson Cancer Center, discusses the factors that determine whether a person's pancreatic cancer is resectable and the importance of this factor in predicting clinical outcomes.
10 min

About GRACEcast Bladder Cancer Video

From the publisher's feed

Oncology experts summarize current and emerging issues in cancer management for patients and caregivers. Information from the Global Resource for Advancing Cancer Education (GRACE) helps people to…